Using fragment-based drug discovery to identify small molecule inhibitors of SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase (RdRp) and future starting points for other Coronaviruses
- Scanlon, Martin (Chief Investigator (CI))
- Angell, Richard (Primary Chief Investigator (PCI))
Project: Research